249 related articles for article (PubMed ID: 30804117)
1. The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.
Zhu L; Cho E; Zhao G; Roh MR; Zheng Z
In Vivo; 2019; 33(2):393-400. PubMed ID: 30804117
[TBL] [Abstract][Full Text] [Related]
2. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
[TBL] [Abstract][Full Text] [Related]
3. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
4. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Gil-Montoya JA
Head Neck; 2019 Jun; 41(6):1963-1978. PubMed ID: 30597652
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
[TBL] [Abstract][Full Text] [Related]
9. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z; Qin J; Wang D; Geng S
J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
[TBL] [Abstract][Full Text] [Related]
10. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS.
Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y
J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922
[TBL] [Abstract][Full Text] [Related]
11. CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway.
Chu Z; Zhang X; Li Q; Hu G; Lian CG; Geng S
Int J Oncol; 2019 May; 54(5):1534-1544. PubMed ID: 30816486
[TBL] [Abstract][Full Text] [Related]
12. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA expression in cutaneous squamous cell carcinoma.
Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
[TBL] [Abstract][Full Text] [Related]
14. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Ma X; Wu D; Zhang X; Shao X; Hu G
Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas.
Stojadinovic O; Ramirez H; Pastar I; Gordon KA; Stone R; Choudhary S; Badiavas E; Nouri K; Tomic-Canic M
Arch Dermatol Res; 2017 Mar; 309(2):133-139. PubMed ID: 28013372
[TBL] [Abstract][Full Text] [Related]
16. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
18. Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells.
Tsunoda K; Oikawa H; Tada H; Tatemichi Y; Muraoka S; Miura S; Shibazaki M; Maeda F; Takahashi K; Akasaka T; Masuda T; Maesawa C
J Invest Dermatol; 2011 Aug; 131(8):1710-9. PubMed ID: 21562571
[TBL] [Abstract][Full Text] [Related]
19. Wnt1 and SFRP1 as potential prognostic factors and therapeutic targets in cutaneous squamous cell carcinoma.
Halifu Y; Liang JQ; Zeng XW; Ding Y; Zhang XY; Jin TB; Yakeya B; Abudu D; Zhou YM; Liu XM; Hu FX; Chai L; Kang XJ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420949
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
Robinson DJ; Patel A; Purdie KJ; Wang J; Rizvi H; Hufbauer M; Ostano P; Akgül B; Chiorino G; Harwood CA; Bergamaschi D
J Invest Dermatol; 2019 Aug; 139(8):1658-1671.e8. PubMed ID: 30710576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]